Obesity in Cancer Survivors on the Rise

This article originally appeared here.
Increasing Prevalence of Obesity in Cancer Survivors
Increasing Prevalence of Obesity in Cancer Survivors

(HealthDay News) -- From 1997 to 2014 the estimated rate of annual increase in obesity prevalence was higher for adults with a history of cancer, according to a study published online July 25 in the Journal of Clinical Oncology.

Heather Greenlee, Ph.D., from Columbia University in New York City, and colleagues examined trends in obesity prevalence among cancer survivors by using a population-based nationally representative sample of 538,969 noninstitutionalized U.S. adults. A total of 32,447 cancer survivors were identified, with breast, prostate, and colorectal cancer the most common diagnoses.

The researchers observed increases in the prevalence of obesity from 1997 to 2014, from 22.4 to 31.7 percent in cancer survivors and from 20.9 to 29.5 percent in adults without a history of cancer. The estimated rate of annual increase in obesity prevalence was higher for adults with a history of cancer than in those without a history of cancer. The estimated rate of annual increase in prevalence of obesity was 3.1 and 3.7 percent, respectively, for female and male colorectal cancer survivors; 3 percent for breast cancer survivors; and 2.1 percent for prostate cancer survivors. Colorectal cancer survivors, breast cancer survivors, and non-Hispanic blacks had the highest rates of increasing obesity burden.

"From 1997 to 2014, obesity increased more rapidly among adult cancer survivors compared with the general population," the authors write.

Two authors disclosed financial ties to EHE International.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs